A Randomized,Double-Blind,Placebo-Controlled, PhaseIIStudy of Regorafenib Versus Placebo in Advanced/Metastatic,Treatment-RefractoryLiposarcoma: Results from theSARC024Study

Authors

R. F. Riedel
K. Ballman
Y. Lu
S. Attia
E. T. Loggers
K. N. Ganjoo
M. B. Livingston
W. Chow
J. Wright
R. G. Maki, Zucker School of Medicine at Hofstra/Northwell
+10 additional authors

Publication Date

2020

Journal Title

Oncologist

Volume Number

25

Issue Number

11

Pages

e1655-e1662

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Hematology/Medical Oncology

PMID

32701199

DOI

10.1634/theoncologist.2020-0679